These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 25188528

  • 1. Soluble guanylate cyclase as a novel treatment target for osteoporosis.
    Joshua J, Schwaerzer GK, Kalyanaraman H, Cory E, Sah RL, Li M, Vaida F, Boss GR, Pilz RB.
    Endocrinology; 2014 Dec; 155(12):4720-30. PubMed ID: 25188528
    [Abstract] [Full Text] [Related]

  • 2. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
    Kalyanaraman H, Ramdani G, Joshua J, Schall N, Boss GR, Cory E, Sah RL, Casteel DE, Pilz RB.
    J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
    [Abstract] [Full Text] [Related]

  • 3. Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes.
    Kalyanaraman H, Schwaerzer G, Ramdani G, Castillo F, Scott BT, Dillmann W, Sah RL, Casteel DE, Pilz RB.
    Diabetes; 2018 Apr; 67(4):607-623. PubMed ID: 29301852
    [Abstract] [Full Text] [Related]

  • 4. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
    Salloum FN, Das A, Samidurai A, Hoke NN, Chau VQ, Ockaili RA, Stasch JP, Kukreja RC.
    Am J Physiol Heart Circ Physiol; 2012 Mar 15; 302(6):H1347-54. PubMed ID: 22268103
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase G2 activation restores Wnt signaling and bone mass in glucocorticoid-induced osteoporosis in mice.
    Pal China S, Kalyanaraman H, Zhuang S, Cabriales JA, Sah RL, Pilz RB.
    JCI Insight; 2024 Jun 17; 9(14):. PubMed ID: 38885330
    [Abstract] [Full Text] [Related]

  • 6. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y, Gross S, Eckerle LG, Hertrich I, Busch M, Busch R, Riad A, Rauch BH, Stasch JP, Dörr M, Felix SB.
    Eur J Pharmacol; 2015 Nov 15; 767():1-9. PubMed ID: 26407652
    [Abstract] [Full Text] [Related]

  • 7. YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts.
    Wang JW, Yeh CB, Chou SJ, Lu KC, Chu TH, Chen WY, Chien JL, Yen MH, Chen TH, Shyu JF.
    J Bone Miner Metab; 2018 Sep 15; 36(5):508-518. PubMed ID: 28983668
    [Abstract] [Full Text] [Related]

  • 8. Cinaciguat in combination with insulin induces a favorable effect on implant osseointegration in type 2 diabetic rats.
    Jia T, Wang YN, Zhang J, Hao X, Zhang D, Xu X.
    Biomed Pharmacother; 2019 Oct 15; 118():109216. PubMed ID: 31319371
    [Abstract] [Full Text] [Related]

  • 9. Pro-survival effects of 17β-estradiol on osteocytes are mediated by nitric oxide/cGMP via differential actions of cGMP-dependent protein kinases I and II.
    Marathe N, Rangaswami H, Zhuang S, Boss GR, Pilz RB.
    J Biol Chem; 2012 Jan 06; 287(2):978-88. PubMed ID: 22117068
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
    Korkmaz S, Radovits T, Barnucz E, Hirschberg K, Neugebauer P, Loganathan S, Veres G, Páli S, Seidel B, Zöllner S, Karck M, Szabó G.
    Circulation; 2009 Aug 25; 120(8):677-86. PubMed ID: 19667237
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G, Burnett JC.
    Cardiovasc Drug Rev; 2007 Aug 25; 25(1):30-45. PubMed ID: 17445086
    [Abstract] [Full Text] [Related]

  • 12. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
    Chester M, Tourneux P, Seedorf G, Grover TR, Gien J, Abman SH.
    Am J Physiol Lung Cell Mol Physiol; 2009 Aug 25; 297(2):L318-25. PubMed ID: 19465519
    [Abstract] [Full Text] [Related]

  • 13. Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure.
    Tamargo J, Duarte J, Caballero R, Delpón E.
    Curr Opin Investig Drugs; 2010 Sep 25; 11(9):1039-47. PubMed ID: 20730699
    [Abstract] [Full Text] [Related]

  • 14. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice.
    Lee EJ, Kim JL, Kim YH, Kang MK, Gong JH, Kang YH.
    Phytomedicine; 2014 Sep 15; 21(10):1208-15. PubMed ID: 24932975
    [Abstract] [Full Text] [Related]

  • 15. Effects of soluble guanylate cyclase activation on heart transplantation in a rat model.
    Loganathan S, Korkmaz-Icöz S, Radovits T, Li S, Mikles B, Barnucz E, Hirschberg K, Karck M, Szabó G.
    J Heart Lung Transplant; 2015 Oct 15; 34(10):1346-53. PubMed ID: 26210750
    [Abstract] [Full Text] [Related]

  • 16. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.
    Radovits T, Korkmaz S, Miesel-Gröschel C, Seidel B, Stasch JP, Merkely B, Karck M, Szabó G.
    Eur J Cardiothorac Surg; 2011 Feb 15; 39(2):248-55. PubMed ID: 20591683
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of Phosphodiesterase 5 Promotes the Aromatase-Mediated Estrogen Biosynthesis in Osteoblastic Cells by Activation of cGMP/PKG/SHP2 Pathway.
    Wisanwattana W, Wongkrajang K, Cao DY, Shi XK, Zhang ZH, Zhou ZY, Li F, Mei QG, Wang C, Suksamrarn A, Zhang GL, Wang F.
    Front Endocrinol (Lausanne); 2021 Feb 15; 12():636784. PubMed ID: 33776932
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide as a mediator of estrogen effects in osteocytes.
    Joshua J, Kalyanaraman H, Marathe N, Pilz RB.
    Vitam Horm; 2014 Feb 15; 96():247-63. PubMed ID: 25189390
    [Abstract] [Full Text] [Related]

  • 19. Fas receptor is required for estrogen deficiency-induced bone loss in mice.
    Kovacic N, Grcevic D, Katavic V, Lukic IK, Grubisic V, Mihovilovic K, Cvija H, Croucher PI, Marusic A.
    Lab Invest; 2010 Mar 15; 90(3):402-13. PubMed ID: 20084056
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide regulation of gene transcription via soluble guanylate cyclase and type I cGMP-dependent protein kinase.
    Idriss SD, Gudi T, Casteel DE, Kharitonov VG, Pilz RB, Boss GR.
    J Biol Chem; 1999 Apr 02; 274(14):9489-93. PubMed ID: 10092632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.